The built-in AI-trained algorithms will empower users to proactively intervene when their glucose levels require attention and before a complication can even occur
Olverembatinib, a novel drug developed by Ascentage Pharma with support from the National Major New Drug Development program
Acquisition provides Ligand with the royalty rights to QARZIBA, a highly differentiated, commercial oncology drug marketed in 35 countries by global pharmaceutical company Recordati S.p.A.
Felzartamab demonstrated positive interim results from the Phase 2 IgA nephropathy (IgAN) study
Aim of the collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization
Ibara will drive AI-powered clinical research innovation
This existing GMP compliant facility, located at Bharuch (Unit-1) with ongoing expansion part of the company's strategic capex initiative
Aster CMI Hospital has successfully implemented several key digital health initiatives contributing to this accreditation
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
Austin assumes role from Glenn F. Tilton, who will continue to serve as an independent director
Subscribe To Our Newsletter & Stay Updated
